Opendata, web and dolomites

SINUSHUNT SIGNED

SinuShunt – New disruptive medical device for treatment of hydrocephalus

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SINUSHUNT project word cloud

Explore the words cloud of the SINUSHUNT project. It provides you a very rough idea of what is the project "SINUSHUNT" about.

patient    care    endoscope    natural    operations    abdomen    dynamics    annually    6b    additional    period    propelled    population    instead    option    inefficiency    neurosurgeons    either    draining    blockage    untreated    uses    industry    failing    aging    1950s    internationally    tools    surgical    employ    112    sinus    fluid    valued    life    shunts    implantable    hydrocephalus    cerebrospinal    quality    normal    cagr    complications    resorption    devastating    sinushunt    stent    reducing    market    2023    infections    substance    outlet    shunting    roi    significantly    place    fatal    advantages    health    chest    medical    avoiding    hunt    obstruction    left    lot       shunt    close    drainage    brain    5b    2b    amount    people    steadily    patients    placed    innovation    thereof    competitive    constantly    time    centrally    implantation    sell    csf    neurological    brings    device    conventional    caused    incl    re    vein    2026    disruptive    central    accumulation    treatment    diagnostic    solution   

Project "SINUSHUNT" data sheet

The following table provides information about the project.

Coordinator
CSF-DYNAMICS A/S 

Organization address
address: GAMMEL LUNDTOFTEVEJ 1 D
city: KGS. LYNGBY
postcode: 2800
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Denmark [DK]
 Total cost 998˙375 €
 EC max contribution 698˙862 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-02-01   to  2021-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CSF-DYNAMICS A/S DK (KGS. LYNGBY) coordinator 698˙862.00

Map

 Project objective

Hydrocephalus is a devastating neurological condition caused by accumulation of cerebrospinal fluid (CSF) on brain, and If left untreated, it can be fatal. The only treatment option is surgical, either implantation of a shunting device placed centrally in the brain, or, in some cases, by use of an endoscope going through the brain substance to its central part. The main problem in the industry is that conventional treatment systems (shunts) are based on a technology from 1950s and they are failing on average in 4-8 years, due to blockage or over-drainage. This results in 100 000 re-operations annually and brings a lot of complications (incl. increased infections) to the patient. Furthermore, this inefficiency represents an additional cost of €1.5B for the health care systems annually. To offer a solution to these problems, CSF-Dynamics is developing a new disruptive implantable medical device for treatment of hydrocephalus. The main innovation is draining the cerebrospinal fluid into sinus vein that is a natural resorption place of CSF, instead of conventional chest or abdomen. The hunt system uses novel stent technology as an outlet into the sinus vein, to avoid obstruction. SinuShunt competitive advantages are: 1) significantly increased life-time of the shunt, therefore reducing amount of re-operations; 2) Better quality of life for the patient due to the close to normal drainage of the brain-fluid, avoiding over-drainage and complications thereof. Hydrocephalus market is currently valued at €1.2B and is expected to reach a value of €1.6B by 2023. The market is steadily growing at CAGR of 4.4% during this time period. The market growth is propelled by growth in aging of population, increasing awareness of the condition and constantly improving diagnostic tools. Our end-users are hydrocephalus patients and users neurosurgeons. By 2026 we expect to sell our solution internationally, employ additional 112 people, and achieve a ROI of 40.6.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SINUSHUNT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SINUSHUNT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

LIVELMIA (2019)

Innovative assay for microRNAs analysis

Read More  

MindTrack (2019)

Analysis of eye vergence responses for the early detection and monitoring of cognitive and mental disorders

Read More  

MHS (2019)

Metal Hydrides Hydrogen Storage

Read More